10-K Decoder · All companies

Lexicon Pharmaceuticals, Inc.

LXRX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$49.8M$31.1M+60.2%
Operating income−$48.9M−$197M+75.2%
Net income−$50.3M−$200M+74.9%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$11.2M$14.2M−21.1%
Operating income−$14.5M−$12.2M−18.9%
Net income−$14.0M−$12.8M−9.4%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Lexicon's revenue in FY2025?
$49.8M in FY2025 (Fiscal year ended Dec 31, 2025), +60.2% vs $31.1M a year earlier, per its 10-K filed Mar 2026.
Was Lexicon profitable in FY2025?
No: net income was −$50.3M and operating income −$48.9M in FY2025.
What was Lexicon's revenue in Q3 2026?
$11.2M (−21.1% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.